|
Home | Current Issue | Past Issues | Submissions | Subscribe | Contact | Dental Links |

| Home |
| Current Issue |
| Past Issues |
| Submissions |
| Subscribe |
| Contact |
| Dental Links |
Winter 2004: Volume
29, Number 2 |
|
| Pediatric
Oral Pathology |
|
| Crouzonodermoskeletal syndrome |
|
Crouzon craniostenosis [MIM
123500], is identified on the basis of the additional phenotypical
manifestations of acanthosis nigricans, vertebral changes and
cementomas of the jaws. Choanal atresia and hydrocephalus are
other features. The molecular defect in CDSS is a point mutation
in the FGFR3 gene on chromosome 4p, whereas, the mutation in the
Crouzon syndrome is in the FGFR2 gene at 10q25.3-26.An affected
girl aged 2 years presented at the UWC dental genetics unit with
a prior diagnosis of Crouzon syndrome. Choanal atresia had necessitated
a permanent tracheostomy, and hydrocephalus was managed by a shunt
operation. Clinical examination revealed acanthosis nigricans
in the axilliary regions, a diagnosis confirmed by a biopsy of
the lesion. Eruption of the primary dentition was delayed with
only six out of twenty teeth present. Radiographic examination
conducted shortly after birth revealed the presence of several
tooth buds in both the maxillae and the mandible. The delayed
eruption of the teeth will be of significance in future orthodontic
and maxillofacial measures for the improvement of the patient’s
facial Crouzonodermoskeletal syndrome (CDSS) was separated from
the classical appearance. Molecular investigations in the girl
and her parents are underway. If the specific mutation in FGFR3
is observed, a positive diagnosis of CDSS will be confirmed and
the status of her parents and other family members will be determined.
On this basis, appropriate genetic management can be offered to
the kindred. |
|
| Full Text | |
| © 2007 The Journal of Clinical Pediatric Dentistry |